Pay in 4 interest-free payments of $8.00 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
or a history of clotting disorders
seek immediate medical assistance to ensure proper care
Active Ingredient Avanafil Therapeutic Class Phosphodiesterase Type 5 (PDE5) Inhibitor (Second-Generation) Primary Formulation Next-Gen Ultra-Fast Acting Series Concentration Strength 200 mg per film-coated oral tablet Administration Route Oral consumption (Swallowed whole with plain water) Packaging Format Premium secure
and improve overall quality of life
Ranitidine 150 Mg (Generic) Quantity:300 Tablet/s or a history of clotting
